Mesoblast (MEOBF) FCF Margin Growth (3y) (2017 - 2023)
Powered by 
Analysis
Mesoblast (MEOBF) FCF Margin Growth (3y) (2017 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -63,107.00 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 4.25 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 12,129.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 190,033.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -1.35 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 86,497.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 10,262.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 371.00 |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -389,193.00 |
| Dec 31, 2022 | 123,885.00 |
| Sep 30, 2022 | 104,183.00 |
| Mar 31, 2022 | 92,477.00 |
| Dec 31, 2021 | -41,059.00 |
| Sep 30, 2021 | 67,432.00 |
| Jun 30, 2021 | 22,173.00 |
| Mar 31, 2021 | 55,420.00 |
| Dec 31, 2020 | -125,361.00 |
| Sep 30, 2020 | -42,449.00 |
| Mar 31, 2020 | 273,234.00 |
| Dec 31, 2019 | 417,528.00 |
| Sep 30, 2019 | 518,140.00 |
| Mar 31, 2019 | -96,017.00 |
| Sep 30, 2018 | 37,594.00 |
| Mar 31, 2018 | -129,212.00 |
| Sep 30, 2017 | -104,600.00 |